Translational Control of Immune Evasion in Cancer: Trends in Cancer

Por um escritor misterioso

Descrição

Translational Control of Immune Evasion in Cancer: Trends in Cancer
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Monocytes and Macrophages in the Cancer Immunity Cycle — Journal
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Frontiers Cancer Immune Evasion Through Loss of MHC Class I
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Major cancer immune surveillance and immune evasion mechanisms
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Gut Microbiota in Cancer Immune Response and Immunotherapy: Trends
Translational Control of Immune Evasion in Cancer: Trends in Cancer
The plasticity of mRNA translation during cancer progression and
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Frontiers Mechanisms of immune evasion by head and neck cancer
Translational Control of Immune Evasion in Cancer: Trends in Cancer
PD-L1-mediated immune evasion in triple-negative breast cancer is
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Harnessing the immune system against cancer: current immunotherapy
Translational Control of Immune Evasion in Cancer: Trends in Cancer
An integrated model of N6-methyladenosine regulators to predict
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Targeting the sialoglycan-Siglec axis for cancer immunotherapy
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Metabolic regulation of the cancer-immunity cycle: Trends in
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Epigenetic dysregulation of immune-related pathways in cancer
Translational Control of Immune Evasion in Cancer: Trends in Cancer
IJMS, Free Full-Text
de por adulto (o preço varia de acordo com o tamanho do grupo)